Stockreport

Nasdaq Welcomes Allogene Therapeutics, Inc. (Nasdaq: ALLO) To The Nasdaq Stock Market

Nasdaq, Inc.  (NDAQ) 
Last nasdaq, inc. earnings: 4/22 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.nasdaq.com
PDF NEW YORK, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic [Read more]